Blog
The epidemiology of databases: Part II: Four principles of generating real-world evidence
In a recent comment letter to the U.S. Food and Drug Administration, Aetion outlined key ...
Blog
The epidemiology of databases: Part I: Four principles of working with real-world data
As the U.S. Food and Drug Administration continues its formal exploration of the use of ...
Blog
Where public health and quantitative science overlap: A conversation with senior scientist Erin Comerford
Health care tech and data grab all the headlines, but science matters most. Erin ...
Blog
Welcome to the Evidence Hub
At Aetion, we work at the crossroads of health care: the point at which patients, ...
Blog
Framework for FDA’s Real-World Evidence Program: Dr. Sebastian Schneeweiss considers implications for biopharma
In December 2018, the U.S. Food and Drug Administration unveiled its strategy to assess ...
Blog
Leading change at Pfizer: A conversation with Chris Boone
As costs soar and patients wait, forward-looking pharmaceutical companies are exploring ...
Blog
Four questions to ask your data
A vital step in generating real-world evidence is understanding where the available data ...
Blog
A year of acceleration: Looking ahead at 2019
The place where two rivers meet is called a confluence—a good word for the year ahead in ...